Rxrevu DBA Arrive Health
Improving the value of healthcare through better prescribing decisions.
Based in CO
AI Overview
With $290K in lobbying spend across 19 quarterly filings, Rxrevu DBA Arrive Health is an active lobbying client. Their lobbying covers 1 issue area. Active from 2020 to 2023.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2020 | $50K |
| 2021 | $110K |
| 2022 | $130K |
| 2023 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Rxrevu DBA Arrive Health disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
Issues relating to the use of real-time benefit tools in healthcare.
Issues relating to the use of real-time benefit tools in healthcare including S. 2543, the Prescription Drug Pricing Reduction Act; HR 3408, the Shop Rx Act; HR 3415 the Real-Time Beneficiary Drug Cos
Issues relating to the use of real-time benefits tools in healthcare, interoperability, and data privacy and sharing in healthcare
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.